Residual reversibility in COPD subjects treated by long acting bronchodilatators

M. Picaud (Lille, France), O. Le Rouzic (Lille, France), H. Salvator (Suresnes, France), H. Neveu (Suresnes, France), P. Devillier (Suresnes, France), L. Couderc (Suresnes, France), T. Perez (Lille, France)

Source: International Congress 2018 – Biomarkers for evaluating COPD
Session: Biomarkers for evaluating COPD
Session type: Thematic Poster
Number: 1068
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Picaud (Lille, France), O. Le Rouzic (Lille, France), H. Salvator (Suresnes, France), H. Neveu (Suresnes, France), P. Devillier (Suresnes, France), L. Couderc (Suresnes, France), T. Perez (Lille, France). Residual reversibility in COPD subjects treated by long acting bronchodilatators. 1068

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: